Steven Belknap
Steven Belknap
Assistant Professor of Medicine, Northwestern University
Email verificata su
Citata da
Citata da
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project
JR Nebeker, R Virmani, CL Bennett, JM Hoffman, MH Samore, J Alvarez, ...
Journal of the American College of Cardiology 47 (1), 175-181, 2006
Pure red-cell aplasia and epoetin therapy
CL Bennett, S Luminari, AR Nissenson, MS Tallman, SA Klinge, ...
New England Journal of Medicine 351 (14), 1403-1408, 2004
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
AM Evens, BD Jovanovic, YC Su, DW Raisch, D Ganger, SM Belknap, ...
Annals of Oncology 22 (5), 1170-1180, 2011
A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia
S Nelson, SM Belknap, RW Carlson, D Dale, B DeBoisblanc, S Farkas, ...
The Journal of infectious diseases 178 (4), 1075-1080, 1998
Adverse drug events in emergency department patients
JW Hafner Jr, SM Belknap, MD Squillante, KA Bucheit
Annals of emergency medicine 39 (3), 258-267, 2002
Acute tolerance to cocaine in humans
JJ Ambre, SM Belknap, J Nelson, TI Ruo, SG Shin, AJ Atkinson Jr
Clinical Pharmacology & Therapeutics 44 (1), 1-8, 1988
Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans
J Ambre, TI Ruo, J Nelson, S Belknap
Journal of analytical toxicology 12 (6), 301-306, 1988
The research on adverse drug events and reports (RADAR) project
CL Bennett, JR Nebeker, EA Lyons, MH Samore, MD Feldman, JM McKoy, ...
Jama 293 (17), 2131-2140, 2005
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non–HIV-infected individuals
SM Patel, S Johnson, SM Belknap, J Chan, ES Beverly, C Bennett
JAIDS Journal of Acquired Immune Deficiency Syndromes 35 (2), 120-125, 2004
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from theá…
BJ Edwards, AD Bunta, J Lane, C Odvina, DS Rao, DW Raisch, ...
The Journal of bone and joint surgery. American volume 95 (4), 297, 2013
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Researchá…
CL Bennett, D Cournoyer, KR Carson, J Rossert, S Luminari, AM Evens, ...
Blood 106 (10), 3343-3347, 2005
Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stress
RT Chatterton Jr, PD Hill, JC Aldag, KR Hodges, SM Belknap, ...
The Journal of Clinical Endocrinology & Metabolism 85 (10), 3661-3668, 2000
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reportsá…
LA Ladewski, SM Belknap, JR Nebeker, O Sartor, EA Lyons, TC Kuzel, ...
Journal of clinical oncology 21 (20), 3859-3866, 2003
Amiodarone-associated optic neuropathy: a critical review
RS Passman, CL Bennett, JM Purpura, R Kapur, LN Johnson, DW Raisch, ...
The American journal of medicine 125 (5), 447-453, 2012
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report
B Nardone, E Saddleton, AE Laumann, BJ Edwards, DW Raisch, ...
Pediatric radiology 44 (2), 173-180, 2014
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin
E Fung, NA Patsopoulos, SM Belknap, DJ O'Rourke, JF Robb, ...
Seminars in thrombosis and hemostasis 38 (08), 893-904, 2012
Clinical features and correlates of gemcitabine‐associated lung injury: Findings from the RADAR project
SM Belknap, TM Kuzel, PR Yarnold, N Slimack, EA Lyons, DW Raisch, ...
Cancer: Interdisciplinary International Journal of the American Cancerá…, 2006
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration andá…
CL Bennett, JR Nebeker, PR Yarnold, CC Tigue, DA Dorr, JM McKoy, ...
Archives of internal medicine 167 (10), 1041-1049, 2007
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, ...
PeerJ 5, e3020, 2017
High-alert’medications and patient safety
S Belknap
Int J Qual Health Care 13 (4), 339, 2001
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20